$LLY · Wissner-Gross: Eli Lilly approaching $1T as market signals longevity drugs and AI as future industries

episode briefing

extracted intelligence

Peter H. Diamandis

Demis Hassabis on AGI, Robots Scale Production, and Elon’s $1T Mars-Shot Comp | EP 253

now viewing▶ 78:20

Wissner-Gross: Eli Lilly approaching $1T as market signals longevity drugs and AI as future industries

2026-05-07 · 5 company · 8 thematic

sentiment

5 bull0 bear0 neu

speakers

salim ismail

Salim Ismail is a serial entrepreneur and strategist who co-wrote Exponential Organizations (ExO 1.0 and 2.0). He leads the OpenExO community of 50,000 people in 150 countries and has worked with Fortune 500 companies (P&G, Siemens Energy, HP, Black & Decker) on edge innovation. He is launching the Organizational Singularity (ExO 3.0) as a living AI book via a Claude skill.

dave blundin

Dave Blundin (DB2) is Peter Diamandis' longtime friend and MIT roommate, partner at Link Ventures, and described as a guru on exponential investing. He focuses on moonshot-stage companies in AI, robotics, and space.

alex wissner-gross

Computer scientist, physicist, entrepreneur and investor whose work spans artificial intelligence and complex systems. He is the founder and managing partner of Reified.

quote

“Eli Lilly, which has been publicly traded for a long time, but is either already at a trillion or about to cross a trillion on its present trajectory. And I think that's the market speaking very clearly that longevity drugs and AI are the…”

—alex wissner-gross

now playing · $LLY

$COLOSSAL-BIOSCIENCESbullish· mediumsalim ismail

Ismail: De-extinction is first step toward computationally resurrecting all extinct species and humans

Colossal's de-extinction work is a special case of a broader Russian Cosmist program to use technology to bring back every species and every human who ever lived, computationally…

$SPCX···bullish· highdave blundin

Blundin: SpaceX moonshot comp package aligns investors with 1000x outcomes

The all-or-nothing compensation package tied to a Mars colony of 1M+ people and a $7.5T valuation creates a new corporate governance model for moonshot companies where investors w…

$FIGUREbullish· highdave blundin

Blundin: Robotics is the next decade-long wave as AI commoditizes software

AI writing software so well means pure software investing has limited life; robotics and data centers will be the dominant investment themes for the next decade-plus.

$TSLA···bullish· highdave blundin

Blundin: Tesla will be known as Optimus robot production company, not car maker

Tesla's manufacturing expertise scaling cars will translate to humanoid robots; in 10-20 years Tesla will be known as the Optimus production company, not an auto manufacturer.

$LLY···bullish· highalex wissner-gross

Wissner-Gross: Eli Lilly approaching $1T as market signals longevity drugs and AI as future industries

Eli Lilly's GLP-1 franchise (Mounjaro, retatrutide) is driving it toward a trillion-dollar valuation, and the market is clearly signaling that longevity drugs and AI are the two o…